Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Find ways to apply rewards toward loan principal to reduce balances faster and save on interest through thoughtful payoff planning.
24,194 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Rising fuel costs collide with a blunt political remark, triggering market signals as investors assess the impact on ...
AMD posts a sharp rise in free cash flow as data center demand surges, while Intel bankrolls a costly foundry rebuild...
Nvidia is poised to deliver another strong earnings quarter, but history shows a big print doesn’t always move the st...
Palantir's 2025 results set a high-growth trajectory, but investors want to know how the stock could perform by 2030....
As AI tools reshape how listings are written, a new checklist helps real estate agents: before any MLS post goes live...
The Senate Banking Committee moved the CLARITY Act forward, setting the stage for a broader battle over crypto regula...
Taiwan’s president emphasizes arms sales as the key deterrent to conflict, while Trump questions ongoing support, tri...
Five ETFs are being pitched as the cleanest way to play embodied AI, a thesis many traders say aligns with Jensen Hua...
Oil prices are testing a critical threshold as investors weigh potential spillovers to stocks. Some analysts warn the...
Investors poured money into XRP spot ETFs, lifting cumulative inflows toward $1.4 billion. Despite fresh flows, XRP’s...
Microsoft posts solid Q3 results, showing AI and cloud momentum that investors say could unlock value in Big Tech. Th...